English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/37256
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

DC FieldValueLanguage
dc.contributor.authorBabel, Ingrid-
dc.contributor.authorBarderas, Rodrigo-
dc.contributor.authorPeláez-García, Alberto-
dc.contributor.authorCasal, J. Ignacio-
dc.date.issued2011-06-02-
dc.identifier.citationBMC Biotechnology 11(1): 61 (2011)-
dc.identifier.issn1472-6750-
dc.identifier.urihttp://hdl.handle.net/10261/37256-
dc.description.abstractAbstract Background Antibodies constitute a powerful tool to study protein function, protein localization and protein-protein interactions, as well as for diagnostic and therapeutic purposes. High-throughput antibody development requires faster methodologies with lower antigen consumption. Results Here, we describe a novel methodology to select human monoclonal recombinant antibodies by combining in vitro protein expression, phage display antibody libraries and antibody microarrays. The application of this combination of methodologies permitted us to generate human single-chain variable fragments (scFvs) against two proteins: green fluorescent protein (GFP) and thioredoxin (Trx) in a short time, using as low as 5 μg of purified protein. These scFvs showed specific reactivity against their respective targets and worked well by ELISA and western blot. The scFvs were able to recognise as low as 31 ng of protein of their respective targets by western blot. Conclusion This work describes a novel and miniaturized methodology to obtain human monoclonal recombinant antibodies against any target in a shorter time than other methodologies using only 5 μg of protein. The protocol could be easily adapted to a high-throughput procedure for antibody production.-
dc.description.sponsorshipRB was supported by a JAE-Doc contract (CSIC). AP is a recipient of a predoctoral FPI grant of the Spanish Ministry of Science and Innovation. This research was supported by grants from the Spanish Ministry of Science and Innovation BIO2009-08818 and Colomics Programme of the regional government of Madrid.We acknowledge support by the CSIC Open Access Publication Initiative through its Unit of Information Resources for Research (URICI).-
dc.language.isoeng-
dc.publisherBioMed Central-
dc.relation.isversionofPublisher’s version-
dc.rightsopenAccess-
dc.subjectscFv antibodies-
dc.subjectIn vitro protein expression-
dc.subjectPhage display-
dc.subjectAntibody microarrays-
dc.titleAntibodies on demand: A fast method for the production of human scFvs with minimal amounts of antigen-
dc.typeartículo-
dc.identifier.doi10.1186/1472-6750-11-61-
dc.relation.publisherversionhttp://dx.doi.org/10.1186/1472-6750-11-61-
dc.identifier.e-issn1472-6750-
dc.date.updated2011-06-28T14:05:16Z-
dc.description.versionPeer Reviewed-
dc.rights.holderBabel et al.; licensee BioMed Central Ltd.-
Appears in Collections:(CIB) Artículos
Files in This Item:
File Description SizeFormat 
1472-6750-11-61.xml73,52 kBXMLView/Open
1472-6750-11-61-S2.PDF72,38 kBAdobe PDFThumbnail
View/Open
1472-6750-11-61.pdf6,2 MBAdobe PDFThumbnail
View/Open
1472-6750-11-61-S1.PDF73,54 kBAdobe PDFThumbnail
View/Open
Show simple item record
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.